Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,716,209
+$137,123 QoQ
Shares Held
10,695
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#2,079
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCM Capital Management Inc holds $6,711,620 across 8 Drug Manufacturers - General names. JNJ ranks #1 (40.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
10,695 | $2,716,209 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
8,991 | $1,135,922 | |
| 3 | AMRN |
Amarin Corp Plc\Uk
|
51,362 | $818,710 | |
| 4 | NVS |
Novartis AG
|
3,341 | $523,601 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,930 | $514,546 | |
| 6 | AMGN |
Amgen Inc
|
997 | $361,033 | |
| 7 | PFE |
Pfizer Inc
|
14,441 | $347,739 | |
| 8 | LLY |
ELI LILLY & Co
|
245 | $293,860 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,716,209 | 10,695 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,579,086 | 10,551 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,160,558 | 10,440 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,041,288 | 11,009 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,679,791 | 10,997 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,821,918 | 10,986 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,557,846 | 10,772 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,743,603 | 10,759 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,549,296 | 10,600 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,651,661 | 10,441 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,631,193 | 10,407 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,623,226 | 10,422 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,646,427 | 9,947 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,522,100 | 9,820 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,667,046 | 9,437 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,531,663 | 9,376 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,695,930 | 9,554 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,702,825 | 9,608 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,602,583 | 9,368 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $1,473,203 | 9,122 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,523,021 | 9,245 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,509,061 | 9,182 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,499,988 | 9,531 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||